#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pulmonary fibrosis Small intestine leiomyosarcoma Head and neck cancer Squamous cell carcinoma of the oral cavity Ichthyosis Anal squamous cell carcinoma Acute myeloid leukaemia (in remission) Congenital growth hormone deficiency Neoplasm malignant Myelodysplastic syndrome with excess blasts Philadelphia chromosome positive Breast angiosarcoma metastatic Pancreatic carcinoma metastatic Malignant peritoneal neoplasm Obesity More trials…

    Learn about Rare Diseases

    Congenital nephrogenic diabetes insipidus – Life with Disease Mucous membrane pemphigoid – Life with Disease Lymphangiosarcoma – Life with Disease Hyperoxaluria – Diagnostics Hepatic angiosarcoma – Trials in Disease Factor IX deficiency – Basic Information Rhabdomyosarcoma recurrent Erdheim-Chester disease – Trials in Disease Rett syndrome – Basic Information Uterine leiomyosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ketotifen Hydrogen Fumarate Allogeneic Faecal Microbiota Omp64 Zagociguat Eftrenonacog Alfa Taldefgrobep Alfa Buspirone Hydrochloride Bms-986315 Blood And Related Products Autologous Pancreatic Islets Somatropin Estriol Goserelin Nazartinib Neflamapimod GOLD SODIUM THIOSULFATE Botaretigene Sparoparvovec Transcon Il-2Β/Γ Fluticasone Furoate Divarasib More therapies…

    Learn about Your Condition

    Primary myelofibrosis Complex regional pain syndrome Sepsis Desmoid tumour Choreoathetosis Milk allergy Urethral valves Lung transplant Thermal burn Leukaemia Tumour thrombosis Angiosarcoma recurrent Retinal vein occlusion Injury Pruritus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diagnosis

  • Study on Brain Imaging for Alzheimer’s Disease Using Florquinitau (18F) in Patients with Mild Cognitive Impairment and Early Alzheimer’s Symptoms

    Recruiting

    4 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Florquinitau (18F)
    Belgium

  • Study on the Use of 18F-PI-2620 to Detect Alzheimer’s in People with Down Syndrome

    Recruiting

    2 1 1
    Investigated Diseases:
    • Trisomy 21
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Izaflortaucipir (18F)
    Spain

  • Comparison of Three PET Tau Tracers ([18F]RO948, [18F]PI2620, and [18F]MK-6240) in People with Cognitive Impairment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cognitive disorder
    Investigated Drugs:
    • 2-(6-[18F]Fluoro-Pyridin-3-Yl)-9H-Dipyrido[2,3-B:3′,4′-D]Pyrrole
    • Flutemetamol (18F)
    • Izaflortaucipir (18F)
    Spain

  • Study on the Accuracy of Tau PET ([18F]RO6958948) and Vizamyl (Flutemetamol 18F) in Diagnosing Mild Cognitive Symptoms and Risk of Alzheimer’s Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cognitive disorder
    • Dementia
    • Neurodegenerative disorder
    Investigated Drugs:
    • 2-(6-[18F]Fluoro-Pyridin-3-Yl)-9H-Dipyrido[2,3-B:3′,4′-D]Pyrrole
    • Flutemetamol (18F)
    Sweden

  • Study on the Safety of PD L 506 for Patients with First-Time Colorectal Cancer and Healthy Individuals

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Aminolevulinic Acid Hydrochloride
    Germany

  • Study on Chronic Kidney Disease and Polycystic Kidney Disease Using Pyruvic Acid and MRI for Patients with These Conditions

    Recruiting

    2 1 1
    Investigated Diseases:
    • Congenital cystic kidney disease
    • Chronic kidney disease
    Investigated Drugs:
    • Pyruvic Acid
    Denmark
Previous Page
1 2 3 4 … 22
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!